Recent social media posts suggesting that a local celebrity may be experiencing postpartum depression (PPD) following the ...
Biohaven (BHVN) stock is lower after its major depression disorder drug did not meet the primary goal of a phase 2 trial ...
Here are some of the stocks making notable moves in Friday's premarket action: Biohaven shares tumbled 15% after the biopharmaceutical company said Wednesday that [a Phase 2 study of its treatment for ...
Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison ...
Ketamine, a drug once known mainly as an anesthetic and party drug, is now showing real promise in saving lives. A new study ...
Specific components of air-pollution such as sulfate may up depression risk in older adults, especially those with neurologic comorbidities, new research suggests.
New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.
For some, the holidays, a time most see as a time of joy, can be a difficult season, and mental health experts are pointing ...
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...
Long-term exposure to certain components of fine particulate air pollution was associated with a higher risk of developing depression among older adults.
This pollution -- small enough to penetrate deep into the lungs and bloodstream -- has been linked to depression in previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results